Benign prostatic hyperplasia: An overview of existing treatment
2011
Overview of Treatments for Benign Prostatic Hyperplasia
publication
Evidence: moderate
Author Information
Author(s): Neelima Dhingra, Deepak Bhagwat
Primary Institution: University Institute of Pharmaceutical Sciences, Panjab University
Conclusion
Benign prostatic hyperplasia (BPH) is a common condition in aging men, and various treatment options are available to manage its symptoms effectively.
Supporting Evidence
- BPH is the most common condition in aging men, associated with lower urinary tract symptoms.
- 5α-reductase inhibitors and α1-adrenergic receptor antagonists are effective in managing BPH symptoms.
- Combination therapy may improve clinical efficacy compared to monotherapy.
Takeaway
Benign prostatic hyperplasia is when the prostate gets bigger as men age, causing problems with urination, but there are many ways to help fix it.
Limitations
The long-term outcomes of combination therapies are still awaited.
Participant Demographics
The prevalence of LUTS due to BPH increases with age, affecting a significant percentage of men over 60.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website